P1420: PRE‐CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T‐CELLS FOR THE TREATMENT OF B‐CELL MALIGNANCIES von Aranda Orgilles, B., Chion‐Sotinel, I., Grudman, S., Mumford, B., Dixon, C., Duchateau, P., Galetto, R., Gouble, A., Poirot, L.

Volltext

Gene Editing/Gene Therapies: UCART20X22: ALLOGENEIC DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES von Orgilles, B. Aranda, Chion-Sotinel, I., Skinner, J., Fernandez, J. Postigo, Erler, P., Duchateau, P., Galetto, R., Poirot, L.

Volltext

33 - Gene Editing/Gene Therapies: UCART20X22: ALLOGENEIC DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES von Orgilles, B. Aranda, Chion-Sotinel, I., Skinner, J., Fernandez, J. Postigo, Erler, P., Duchateau, P., Galetto, R., Poirot, L.

Volltext

527: A hormone-dependent feedback-loop controls androgen receptor levels by limiting Midline1, a novel translation enhancer and promoter of oncogenic signaling von Demir, U, Koehler, A, Kickstein, E, Aranda-Orgillés, B, Bu, H, Schweiger, M.R, Schaefer, G, Schweiger, S, Klocker, H, Schneider, R

Volltext

The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex von Aranda-Orgillés, Beatriz, Trockenbacher, Alexander, Winter, Jennifer, Aigner, Johanna, Köhler, Andrea, Jastrzebska, Ewa, Stahl, Joachim, Müller, Eva-Christina, Otto, Albrecht, Wanker, Erich E., Schneider, Rainer, Schweiger, Susann

Volltext